Study of blood vessel health during burn surgery
Part of Injuries & trauma clinical trials.
This trial looks at how a protective layer inside your blood vessels (called the glycocalyx) responds during surgery to remove burned skin. The goal is to improve care for people with major burns.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- At least 20% of your body surface is burned
- You are scheduled for surgery to remove at least 20% of the burned area (including the donor site for skin grafts)
- You are not pregnant
- Your burns are not caused by electricity or chemicals
- You do not have serious heart, kidney, or liver disease, and are not on long-term steroids or immune-suppressing medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue and blood samples from burn patients to improve a computer model that predicts sepsis (a severe infection). The goal is to help doctors identify and treat sepsis earlier in burn patients.
This study tests a new dressing for burns that may need skin grafts. The dressing is made from a gel that helps wounds heal, and the study aims to see if it works better than standard care.
This trial tests a new transparent silicone membrane for treating second-degree burns and skin graft wounds. It may help healing by providing a special surface, and the study will see if it works better than standard dressings.
This study looks at blood vessel cells in three groups: healthy adults, patients having major surgery, and critically ill patients with sepsis. It aims to understand how these cells change in different types of inflammation.
This trial tests whether a “microsurfaced” donor-skin graft can heal deep burn wounds (partial- or full-thickness burns) after recent injury. It may help improve healing when the burn area is large enough and not infected.
This study looks at how major spine surgery affects the inner lining of blood vessels. It measures a substance called syndecan-1 in the blood to understand this damage.
Hear when a new Hemorrhagic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.